Stock Earnings Maxim Group analysts initates a Buy rating for Nuvectis Pharma Inc (NVCT) Nuvectis Pharma Inc’s recent filing unveils that its 10% Owner Mosseri Marlio Charles acquired Company’s shares for reported $44768.0 on
Insiders Updates NVCT short interest jump by 20.1%, reflecting negative sentiment The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Analysts Viewpoint Nuvectis Pharma Inc [NVCT] Investment Appeal on the Rise In a filing, Nuvectis Pharma Inc revealed its 10% Owner Mosseri Marlio Charles acquired Company’s shares for reported $44768.0 on